ELV

ELV

USD

Elevance Health Inc. Common Stock

$316.620+6.160 (1.984%)

实时价格

Healthcare
Healthcare Plans
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$310.460

最高价

$318.790

最低价

$310.000

成交量

0.89M

公司基本面

市值

70.4B

所属行业

Healthcare Plans

国家/地区

United States

交易统计

平均成交量

1.99M

交易所

NYQ

货币

USD

52周价格范围

最低价 $273.71当前价 $316.620最高价 $458.75

相关新闻

Analyst Upgrades

Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400

Mizuho analyst Ann Hynes maintains Elevance Health with a Outperform and lowers the price target from $420 to $400.

查看更多
Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400
Analyst Upgrades

JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394

JP Morgan analyst Lisa Gill maintains Elevance Health with a Overweight and raises the price target from $384 to $394.

查看更多
JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394
Analyst Upgrades

TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380

TD Cowen analyst Ryan Langston maintains Elevance Health with a Buy and raises the price target from $330 to $380.

查看更多
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380
Analyst Upgrades

Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403

Wells Fargo analyst Stephen Baxter maintains Elevance Health with a Overweight and lowers the price target from $412 to $403.

查看更多
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403
Reuters

Elevance beats profit estimates as health insurer keeps costs in check

Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check, sending its shares 3% higher in premarket trading.

查看更多
Elevance beats profit estimates as health insurer keeps costs in check
Analyst Upgrades

Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $359

Morgan Stanley analyst Erin Wright maintains Elevance Health with a Equal-Weight and raises the price target from $316 to $359.

Analyst Upgrades

Goldman Sachs Initiates Coverage On Elevance Health with Neutral Rating, Announces Price Target of $343

Goldman Sachs analyst Scott Fidel initiates coverage on Elevance Health with a Neutral rating and announces Price Target of $343.